ANTIMONY SODIUM TARTRATE manufacturers
|
| | ANTIMONY SODIUM TARTRATE Basic information |
| Product Name: | ANTIMONY SODIUM TARTRATE | | Synonyms: | Antimony sodium oxide tartrate (7CI);Antimonate(2-), bis[μ-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, disodium;Antimonate(2-), bis[μ-[2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4]]di-, disodium, stereoisomer;disodium bis[mu-tartrato(4-)]diantimonate(2-);Sodium antimonyl-L-tartrate, 98+%;emetosodium;ium,stereoisomer;natriumantimonyltartrat | | CAS: | 34521-09-0 | | MF: | C8H4NaO12Sb2- | | MW: | 558.62 | | EINECS: | 252-070-9 | | Product Categories: | | | Mol File: | 34521-09-0.mol |  |
| | ANTIMONY SODIUM TARTRATE Chemical Properties |
| Risk Statements | 20/22-51/53 | | Safety Statements | 61 | | RIDADR | 1549 | | RTECS | CC8050000 | | HazardClass | 6.1 | | PackingGroup | III | | Toxicity | LD i.v. in mice: 25 mg/kg (Fargher, Gray) |
| Provider | Language |
|
ALFA
| English |
| | ANTIMONY SODIUM TARTRATE Usage And Synthesis |
| Uses | Sodium antimonyl L-tartrate is a organometallic reagent with antiinfective properties. | | Uses | Antischistosomal. | | Safety Profile | Poison by
subcutaneous, intravenous, and
intraperitoneal routes. Human toxic effects
by intravenous route. Human mutation data
reported. See also ANTIMONY
COMPOUNDS. When heated to
decomposition it emits toxic fumes of Sb. | | Purification Methods | It crystallises from water. [Beilstein 3 III 1014, 3 IV 1227.] |
| | ANTIMONY SODIUM TARTRATE Preparation Products And Raw materials |
|